Studies have focused on the role of PAI-1 in human adipose tissue and how an elevated PAI-1 level contributes to central obesity (27), metabolic syndrome (28), and future IGT or type 2 diabetes (29). Here, SERPINE1 is linked to metabolic syndrome.